Cochrane · systematic review · CD011317
Home‐based versus clinic‐based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections
Fajardo‐Bernal, L, Aponte‐Gonzalez, J, Vigil, P, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
Sexually Transmitted InfectionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
3
No studies
1
Included studies
NR
No studies 1 · 25%Ungraded 0 · 0%Very low 0 · 0%Low 1 · 25%Moderate 2 · 50%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Home‐based compared with clinic‐based specimen collection for CT and NG
Population: Sexually active people
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Index case management (6 to 12 weeks of Home‐based vs clinic‐based specimen collection | RR 0.88 [0.6, 1.29] | 3 studies · 1566 participants | Moderate Downgraded: risk of bias, imprecision, inconsistency |
Proportion of individuals tested (12 days to 8 weeks of Home‐based vs clinic‐based specimen collection | no estimate extracted | 10 studies · 10479 participants | Low Downgraded: risk of bias, imprecision, inconsistency |
Positive test prevalence Home‐based vs clinic‐based specimen collection | RR 0.72 [0.61, 0.86] | 9 studies · 3041 participants | Moderate Downgraded: risk of bias, imprecision, inconsistency |
Adverse effects of testingc Home‐based vs clinic‐based specimen collection | no estimate extracted | NR | No studies |